Status:

COMPLETED

Hypo-fractionated Postoperative IMRT in Prostate Cancer

Lead Sponsor:

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Collaborating Sponsors:

Catholic University of the Sacred Heart

University of Bologna

Conditions:

Prostate Cancer

Eligibility:

MALE

18-79 years

Phase:

NA

Brief Summary

To report the outcome of hypo-fractionated radiotherapy after radical prostatectomy (RP) for prostate cancer (PCa) using IMRT-SIB. 124 patients with PCa at high risk of relapse after RP or diagnosis o...

Detailed Description

To report the outcome of hypo-fractionated radiation therapy after radical prostatectomy (RP) for prostate cancer (PCa) using intensity-modulated radiation treatment with simultaneous integrated boost...

Eligibility Criteria

Inclusion

  • \> 18 years
  • prior radical prostatectomy with or without lymphadenectomy
  • high-risk patients (positive surgical margins, and/or extracapsular extension, and/or seminal vescicle invasion, and/or probability of nodal metastasis \> 7% calculated by the Roach formula after pelvic lymph node dissection with ≤ 13 nodes removed, and/or presence of any positive pelvic nodes) or patients with biochemical relapse (initial post-surgery serum PSA equal or above 0.2 ng/mL with a second confirmatory PSA of the same value)
  • ECOG performance status 0-1
  • adequate bone marrow function (hemoglobin concentration \> 8 g/dl, white blood cell count \> 3,000/ mm³, platelet count \> 75,000/ mm³)
  • pre-treatment computed tomography (CT) scan or magnetic resonance imaging (MRI) of the abdomen and pelvis
  • bone scan
  • informed consent

Exclusion

  • prior pelvic radiotherapy
  • distant metastases
  • macroscopic residual tumor
  • pelvic or para-aortic nodes at re-evaluation imaging after surgery
  • secondary malignancies
  • genetic syndromes of hyper-radio-sensitivity
  • chronic inflammatory bowel disease
  • previously treated with androgen deprivation therapy
  • previously treated with chemotherapy for prostate cancer

Key Trial Info

Start Date :

September 18 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 18 2014

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT03233672

Start Date

September 18 2007

End Date

September 18 2014

Last Update

March 6 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.